Get started
Author

Darci Zblewski

Observed names: D Zblewski, DARCI L. ZBLEWSKI, Darci L. Zblewski, Darci L. Zblewski, MSN, APRN
OpenAlex ID: A5032947311
A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis
2015 · Ayalew Tefferi, Terra L. Lasho, et al. · New England Journal of Medicine · 325
PDF
Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial
2019 · Naseema Gangat, Christian Marinaccio, et al. · Clinical Cancer Research · 77
Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients
2019 · Tucker Coston, Prateek Pophali, et al. · American Journal of Hematology · 72
PDF
Predictors of survival in WHO-defined hypereosinophilic syndrome and idiopathic hypereosinophilia and the role of next-generation sequencing
2016 · A Pardanani, T Lasho, et al. · Leukemia · 59
Phase 1 study of lenzilumab, a recombinant anti–human GM-CSF antibody, for chronic myelomonocytic leukemia
2020 · Mrinal M. Patnaik, David A. Sallman, et al. · Blood · 55
PDF
Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia
2015 · T L Lasho, C M Finke, et al. · Blood Cancer Journal · 53
PDF
CD123 immunostaining patterns in systemic mastocytosis: differential expression in disease subgroups and potential prognostic value
2015 · A Pardanani, K K Reichard, et al. · Leukemia · 39
Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells
2015 · A Pardanani, T Lasho, et al. · Leukemia · 37
ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis
2015 · Animesh D. Pardanani, Terra L. Lasho, et al. · British Journal of Haematology · 32
PDF
Clonal mast cell disease not meeting WHO criteria for diagnosis of mastocytosis: clinicopathologic features and comparison with indolent mastocytosis
2013 · A Pardanani, D Chen, et al. · Leukemia · 32
Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information
2018 · Ayalew Tefferi, Naseema Gangat, et al. · Mayo Clinic Proceedings · 24
Expression of CD123 (IL-3R-alpha), a Therapeutic Target of SL-401, on Myeloproliferative Neoplasms
2014 · Terra Lasho, Christy Finke, et al. · Blood · 21
Outcome of Myelodysplastic Syndromes Over Time in the United States: A National Cancer Data Base Study From 2004-2013
2019 · Aref Al-Kali, Darci Zblewski, et al. · Mayo Clinic Proceedings · 20
A population‐based study of chronic eosinophilic leukemia‐not otherwise specified in the United States
2020 · Gordon J. Ruan, Caleb J. Smith, et al. · American Journal of Hematology · 17
PDF
Imetelstat, a Telomerase Inhibitor, Induces Morphologic and Molecular Remissions In Myelofibrosis and Reversal Of Bone Marrow Fibrosis
2013 · Ayalew Tefferi, Kebede Begna, et al. · Blood · 17
A population-based study of chronic neutrophilic leukemia in the United States
2020 · Gordon J. Ruan, Caleb J. Smith, et al. · Blood Cancer Journal · 16
PDF
Concurrent activating KIT mutations in systemic mastocytosis
2015 · Terra Lasho, Christy Finke, et al. · British Journal of Haematology · 14
PDF
Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience
2018 · Aref Al-Kali, Ahmed Kamel Abou Hussein, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 13
Mayo Clinic experience with 1123 adults with acute myeloid leukemia
2021 · Kebede H. Begna, Walid Ali, et al. · Blood Cancer Journal · 11
PDF
Frequency of venous thrombotic events in patients with myelodysplastic syndrome and 5q deletion syndrome during lenalidomide therapy
2018 · Omar A. Alkharabsheh, Salwa S. Saadeh, et al. · Annals of Hematology · 11
Safety and tolerability of lurbinectedin (PM01183) in patients with acute myeloid leukemia and myelodysplastic syndrome
2018 · Christopher B. Benton, Kelly S. Chien, et al. · Hematological Oncology · 10
Deletion 5q is frequent in myelodysplastic syndrome (MDS) patients diagnosed with interstitial lung diseases (ILD): Mayo Clinic experience
2016 · Rama Nanah, Darci Zblewski, et al. · Leukemia Research · 10
Prognostic impact of combined NPM1+/FLT3− genotype in patients with acute myeloid leukemia with intermediate risk cytogenetics stratified by age and treatment modalities
2015 · Mehrdad Hefazi, Mustaqeem Siddiqui, et al. · Leukemia Research · 8
ASXL1 and CBL Mutations Are Independently Predictive of Inferior Survival in Advanced Systemic Mastocytosis
2015 · Animesh Pardanani, Terra L. Lasho, et al. · Blood · 7
Hypomethylating agents are effective in shrinking splenomegaly in patients with chronic myelomonocytic leukemia
2015 · Salih Subari, Mrinal Patnaik, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 7
Works count: 64
Citation count: 1,035
H-index: 16
I10-index: 22
Year
Topic
Type